University of Michigan rheumatologist Daniel Clauw, M.D., on the potential benefits and risks of using cannabinoids to treat chronic pain. (©JanMika/Shutterstock.com)
Interleukin-6: Neurologic Impact in Rheumatoid Arthritis
This inflammatory cytokine may be linked to many of the secondary neuroendocrine and psychological symptoms of RA.
Arthritis Numbers Just the Tip of the Iceberg
Previous figures underestimated the burden of arthritis, especially among younger adults.
Juvenile Onset Arthritis Raises Pregnancy Risks
The risk of pregnancy-related complications is further increased when juvenile arthritis persists into adulthood.
Rheumatoid Arthritis Linked with COPD Hospitalization
The risk is nearly twice as high as in the general population, and women are at significantly higher risk.
Digital Coaching Enhances Rheumatoid Arthritis Outcomes
This tool may be used to reduce stressors, improve well-being, and decrease symptoms.
Break From Methotrexate Boosts Flu Shot Efficacy in RA
With a drug holiday, patients with rheumatoid arthritis could improve their response to influenza vaccinations without increasing disease activity.
In RA, No Added Second Malignancy Risk With Biologics
Some physicians have shown reluctance to use these agents for patients who have rheumatoid arthritis and a previous cancer diagnosis.
Biologic Use in Pregnancy Does Not Increase Infant Infection Risk
New evidence is reassuring for women with rheumatoid arthritis who need treatment with a biologic throughout pregnancy.
Fitness Interventions for Rheumatologic Fatigue and Pain
The ACR/ARHP Annual Meeting provided a research update on surrounding issues and strategies for helping patients.
Biosimilars: To Switch or Not to Switch?
The pros and cons of using biosimilar medications shaped the “Great Debate” at this year’s ACR/ARHP Annual Meeting.